456 related articles for article (PubMed ID: 31796646)
1. HIF-2α upregulation mediated by hypoxia promotes NAFLD-HCC progression by activating lipid synthesis via the PI3K-AKT-mTOR pathway.
Chen J; Chen J; Huang J; Li Z; Gong Y; Zou B; Liu X; Ding L; Li P; Zhu Z; Zhang B; Guo H; Cai C; Li J
Aging (Albany NY); 2019 Dec; 11(23):10839-10860. PubMed ID: 31796646
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.
Zhao D; Zhai B; He C; Tan G; Jiang X; Pan S; Dong X; Wei Z; Ma L; Qiao H; Jiang H; Sun X
Cell Signal; 2014 May; 26(5):1030-9. PubMed ID: 24486412
[TBL] [Abstract][Full Text] [Related]
3. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C
Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway.
Chen J; Chen J; Fu H; Li Y; Wang L; Luo S; Lu H
Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E710-E722. PubMed ID: 31430204
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia inducible factor 2α/insulin-like growth factor receptor signal loop supports the proliferation and Oct-4 maintenance of mouse germline stem cells.
Huang YH; Lin MH; Wang PC; Wu YC; Chiang HL; Wang YL; Chang JH; Huang YK; Gu SY; Ho HN; Ling TY
Mol Hum Reprod; 2014 Jun; 20(6):526-37. PubMed ID: 24598112
[TBL] [Abstract][Full Text] [Related]
6. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus increases the anti-cancer effect of Huai Er by regulating hypoxia inducible factor-1α-mediated glycolysis in hepatocellular carcinoma.
Zhou L; Zhao Y; Pan LC; Wang J; Shi XJ; Du GS; He Q
World J Gastroenterol; 2022 Aug; 28(32):4600-4619. PubMed ID: 36157928
[TBL] [Abstract][Full Text] [Related]
8. RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4.
Wang C; Chen Z; Yi Y; Ding Y; Xu F; Kang H; Lin K; Shu X; Zhong Z; Zhang Z; Liu J; Xu Z; Liu L; He X; Chang Y; Zhao Q
Oncogene; 2024 Jan; 43(5):328-340. PubMed ID: 38040804
[TBL] [Abstract][Full Text] [Related]
9. Cross talk between oxidative stress and hypoxia via thioredoxin and HIF-2α drives metastasis of hepatocellular carcinoma.
Cao MQ; You AB; Cui W; Zhang S; Guo ZG; Chen L; Zhu XD; Zhang W; Zhu XL; Guo H; Deng DJ; Sun HC; Zhang T
FASEB J; 2020 Apr; 34(4):5892-5905. PubMed ID: 32157720
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-driven miR-1307-3p promotes hepatocellular carcinoma cell proliferation and invasion by modulating DAB2 interacting protein.
Chen S; Liu R; Wang H; Liu Q
Pathol Res Pract; 2022 Sep; 237():154066. PubMed ID: 35985237
[TBL] [Abstract][Full Text] [Related]
11. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z
Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938
[TBL] [Abstract][Full Text] [Related]
12. HIF-2-dependent expression of stem cell factor promotes metastasis in hepatocellular carcinoma.
Wang X; Dong J; Jia L; Zhao T; Lang M; Li Z; Lan C; Li X; Hao J; Wang H; Qin T; Huang C; Yang S; Yu M; Ren H
Cancer Lett; 2017 May; 393():113-124. PubMed ID: 28153790
[TBL] [Abstract][Full Text] [Related]
13. SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.
Zhang M; Liu S; Chua MS; Li H; Luo D; Wang S; Zhang S; Han B; Sun C
Cell Death Dis; 2019 Aug; 10(8):612. PubMed ID: 31406106
[TBL] [Abstract][Full Text] [Related]
14. mTOR direct crosstalk with STAT5 promotes de novo lipid synthesis and induces hepatocellular carcinoma.
Li T; Weng J; Zhang Y; Liang K; Fu G; Li Y; Bai X; Gao Y
Cell Death Dis; 2019 Aug; 10(8):619. PubMed ID: 31409773
[TBL] [Abstract][Full Text] [Related]
15. Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma.
Bamodu OA; Chang HL; Ong JR; Lee WH; Yeh CT; Tsai JT
Cells; 2020 Mar; 9(3):. PubMed ID: 32197467
[TBL] [Abstract][Full Text] [Related]
16. Oxygen therapy alleviates hepatic steatosis by inhibiting hypoxia-inducible factor-2α.
Yu L; Wang H; Han X; Liu H; Zhu D; Feng W; Wu J; Bi Y
J Endocrinol; 2020 Jul; 246(1):57-67. PubMed ID: 32369776
[TBL] [Abstract][Full Text] [Related]
17. Effect of Glut-1 and HIF-1α double knockout by CRISPR/CAS9 on radiosensitivity in laryngeal carcinoma via the PI3K/Akt/mTOR pathway.
Bao YY; Zhong JT; Shen LF; Dai LB; Zhou SH; Fan J; Yao HT; Lu ZJ
J Cell Mol Med; 2022 May; 26(10):2881-2894. PubMed ID: 35415942
[TBL] [Abstract][Full Text] [Related]
18. HIF-2α regulates CDCP1 to promote PKCδ-mediated migration in hepatocellular carcinoma.
Cao M; Gao J; Zhou H; Huang J; You A; Guo Z; Fang F; Zhang W; Song T; Zhang T
Tumour Biol; 2016 Feb; 37(2):1651-62. PubMed ID: 26307391
[TBL] [Abstract][Full Text] [Related]
19. HIF-2alpha-dependent PAI-1 induction contributes to angiogenesis in hepatocellular carcinoma.
Geis T; Döring C; Popp R; Grossmann N; Fleming I; Hansmann ML; Dehne N; Brüne B
Exp Cell Res; 2015 Feb; 331(1):46-57. PubMed ID: 25489981
[TBL] [Abstract][Full Text] [Related]
20. [EEF1A2 inhibits the p53 function in hepatocellular carcinoma via PI3K/AKT/mTOR-dependent stabilization of MDM4].
Longerich T
Pathologe; 2014 Nov; 35 Suppl 2():177-84. PubMed ID: 25394965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]